Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment
AUTHORS
David S. Siegel / Gary J. Schiller / Christy Samaras / Michael Sebag / Jesus Berdeja / Siddhartha Ganguly / Jeffrey Matous / Kevin Song / Christopher S. Seet / Giampaolo Talamo / Mirelis Acosta-Rivera / Michael Bar / Donald Quick / Bertrand Anz / Gustavo Fonseca / Donna Reece / William E. Pierceall / Weiyuan Chung / Faiza Zafar / Amit Agarwal / Nizar J. Bahlis
